Aleen

Aleen FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Aleen (ALEN.U.CN) as of Oct 21, 2026 is 41.26 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 168.58 % — a change of -75.53% (lower).

FCF Conversion

41.26 %

YoY

-75.53%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Aleen is 2025 41.26 % . FCF Conversion Rate (FCF/EBITDA) of Aleen was 2024 168.58 % . It decreases by -75.53% lower compared to the previous year.

The Aleen FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2022
72.81 CAD
Jan 1, 2023
314.72 CAD
Jan 1, 2024
168.58 CAD
Jan 1, 2025
41.26 CAD
The Aleen FCF Conversion history
YEARFCF ConversionYoY
41.26 %-75.53%
168.58 %-46.44%
314.72 %+332.24%
72.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aleen Stock analysis

What does Aleen do? Aleen Inc generates revenue through its AI-powered health management platform, offering services like the Aleen Symptom Checker for preliminary diagnosis. The company targets individuals seeking self-assessment tools for health symptoms, combining AI analysis with professional medical consultation. Customers use the Aleen Symptom Checker to identify potential health issues and receive guidance on next steps, leveraging the firm's artificial intelligence to interpret personal medical indicators. The platform serves as a comprehensive tool for managing key health metrics, connecting users with healthcare professionals for further evaluation. Aleen Inc's primary product, Aleen Symptom Checker, is designed for end-users who need immediate health insights without visiting a doctor. The service integrates personal health monitoring with professional consultancy, allowing users to input symptoms and receive AI-driven suggestions. The company monetizes this by providing a digital health assessment tool that reduces unnecessary doctor visits through accurate preliminary diagnosis, appealing to health-conscious consumers in the online diagnosis market. The firm operates in the online health management sector, focusing on AI-driven symptom analysis and medical consultancy. Aleen Symptom Checker functions as the core offering, enabling users to assess symptoms and access professional advice. By combining artificial intelligence with medical expertise, Aleen Inc positions itself as a solution for individuals managing their health indicators through a digital platform, targeting users who prefer self-diagnosis tools before seeking professional help. Aleen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aleen stock

FCF Conversion Rate (FCF/EBITDA) of Aleen is 41.26 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Aleen changed from 168.58 % to 41.26 %, representing a -75.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Aleen since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Aleen with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Aleen

All Key Metrics — Aleen